ADC Therapeutics ADCT
NYSE ADCT
$1.13 -0.09 (-6.97%)
As of: Oct 1, 2026 · 12:00 PM EDT

ADC Therapeutics (ADCT) Shares Outstanding (Entity) (2019 - 2026)

Updated

ADC Therapeutics (ADCT) recorded Shares Outstanding (Entity) of 127.44 million in Q2 2026, up 13.3% from 112.5 million a year earlier and up 0.2% from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

For FY2025, ADC Therapeutics reported Shares Outstanding (Entity) of 125.75 million, up 27.2% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for seven straight years, with a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 98.86 million in FY2024 (+20.1%), 82.29 million in FY2023 (+2.0%), 80.64 million in FY2022 (+5.0%) and 76.81 million in FY2021 (+0.1%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2019.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for nine consecutive quarters, with growth averaging 18.8% over the last eight quarters.
  • Peak year-over-year performance for Shares Outstanding (Entity) in the last five years was growth of 28.2% in Q1 2026, against a decline of 7.0% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at 127.17 million (Q1 2026), 125.75 million (Q4 2025) and 112.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 ADC Therapeutics 152.93 Mn -793.27 Mn 16.90 Mn 127.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.44 Mn
Mar 31, 2026 127.17 Mn
Dec 31, 2025 125.75 Mn
Sep 30, 2025 112.63 Mn
Jun 30, 2025 112.50 Mn
Mar 31, 2025 99.18 Mn
Dec 31, 2024 98.86 Mn
Sep 30, 2024 96.69 Mn
Jun 30, 2024 96.47 Mn
Mar 31, 2024 82.78 Mn
Dec 31, 2023 82.29 Mn
Sep 30, 2023 89.04 Mn
Jun 30, 2023 89.04 Mn
Mar 31, 2023 89.04 Mn
Dec 31, 2022 80.64 Mn
Dec 31, 2021 76.81 Mn
Dec 31, 2020 76.72 Mn
Dec 31, 2019 52.10 Mn
API Access

ADC Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ADCT&period=max&api_key=YOUR_API_KEY